| 12275742 |
Heteroaromatic macrocyclic ether chemotherapeutic agents |
Joshua Courtney Horan, Xinxing Tang, Henry Efrem Pelish, Matthew D. Shair, Anupong Tangpeerachaikul |
2025-04-15 |
| 12054498 |
Heteroaromatic macrocyclic ether chemotherapeutic agents |
Joshua Courtney Horan, Xinxing Tang, Henry Efrem Pelish, Matthew D. Shair, Anupong Tangpeerachaikul |
2024-08-06 |
| 12037346 |
Amino-substituted heteroaryls for treating cancers with EGFR mutations |
Kristin L. Andrews, Baudouin Gérard, Joshua Courtney Horan, Henry Efrem Pelish, Matthew D. Shair +2 more |
2024-07-16 |
| 11964961 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2024-04-23 |
| 11667649 |
Heteroaromatic macrocyclic ether chemotherapeutic agents |
Joshua Courtney Horan, Xinxing Tang, Henry Efrem Pelish, Matthew D. Shair, Anupong Tangpeerachaikul |
2023-06-06 |
| 11542278 |
Heteroaromatic macrocyclic ether chemotherapeutic agents |
Joshua Courtney Horan, Xinxing Tang, Henry Efrem Pelish, Matthew D. Shair, Anupong Tangpeerachaikul |
2023-01-03 |
| 11299484 |
Inhibiting fatty acid synthase (FASN) |
Matthew W. Martin, Mary-Margaret Zablocki, Christopher J. Dinsmore, Zhongguo Wang, Xiaozhang Zheng |
2022-04-12 |
| 11247987 |
Inhibiting ubiquitin specific peptidase 30 |
Justin Andrew Caravella, Bingsong Han, Cuixian Liu, Stephanos Ioannidis, Alexandre Joseph Buckmelter +3 more |
2022-02-15 |
| 11014909 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2021-05-25 |
| 10875848 |
Inhibiting fatty acid synthase (FASN) |
Matthew W. Martin, Mary-Margaret Zablocki, Christopher J. Dinsmore, Zhongguo Wang, Xiaozhang Zheng |
2020-12-29 |
| 10696658 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2020-06-30 |
| 10426135 |
Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof |
Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, John David Trzupek +6 more |
2019-10-01 |
| 10421744 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2019-09-24 |
| 10385036 |
Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof |
Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, John David Trzupek +6 more |
2019-08-20 |
| 10336748 |
Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof |
Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, John David Trzupek +6 more |
2019-07-02 |
| 10316021 |
Heteroarylphenoxy benzamide kappa opioid ligands |
Natasha Mariam Kablaoui, Michael Eric Green, Justin Ian Montgomery, Michael Aaron Brodney, Patrick Robert Verhoest +5 more |
2019-06-11 |
| 10227346 |
Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use therof |
Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, John David Trzupek +6 more |
2019-03-12 |
| 10093655 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2018-10-09 |
| 10077272 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
David Lawrence Firman Gray, Lei Zhang, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov +4 more |
2018-09-18 |
| 9868744 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
David Lawrence Firman Gray, Lei Zhang, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov +4 more |
2018-01-16 |
| 9856263 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
David Lawrence Firman Gray, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, Chakrapani Subramanyam |
2018-01-02 |
| 9822097 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2017-11-21 |
| 9688698 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
David Lawrence Firman Gray, Lei Zhang, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov +1 more |
2017-06-27 |
| 9670201 |
Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof |
Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, John David Trzupek +5 more |
2017-06-06 |
| 9617275 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Jotham Wadsworth Coe, John Arthur Allen, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov +9 more |
2017-04-11 |
